University of Pavia Master of Science in Medical and Pharmaceutical Biotechnologies
University of Pavia

University of Pavia

Master of Science in Medical and Pharmaceutical Biotechnologies

Pavia, Italy

MSc

2 years

English

Full time

14 Sep 2026

EUR 400 / per year **

On-Campus

* 1st call dedicated to EU and NON-EU applicants

** students may be eligible to apply for a flat rate or to tuition fees calculated according to their family income

Key Summary

    About : The Master's Degree in Medical and Pharmaceutical Biotechnologies equips students with advanced knowledge in biotechnology applications in health and pharmaceuticals. The program covers areas like drug development, diagnostics, and genetic engineering. Students engage in practical learning, focusing on current trends and innovations in the biotechnology field.
    Career Outcomes : Graduates can pursue careers in various domains, including biotechnology, pharmaceutical industries, and clinical research. Potential roles include research scientist, quality control analyst, and regulatory affairs specialist. The program prepares students for impactful positions in healthcare innovation and biotechnology development.

The Master’s Degree program in Medical and Pharmaceutical Biotechnologies prepares graduates with highly skilled in designing, analysing and researching biotechnologies in the biomedical and pharmaceutical field.

During a common first year, the students acquire skills and knowledge on the fundamentals of biotechnology, particularly concerning:

  • stem cells and their use in various research fields;
  • genetics in normal conditions and its modifications in diseases;
  • engineered proteins and on RNA technology, as well as their dynamic interaction (system biology);
  • biotechnological applications in biochemical/biomolecular diagnostics and in the development of biological markers;
  • the biochemical and physiological aspects of human cells, tissues and organisms;
  • the basis of human pathological processes of an infectious, metabolic, degenerative and tumor type, with reference to their cellular pathogenetic and molecular mechanisms;

In the second year, the student will choose between two curricula:

  • The Medical Biotechnologies curriculum focuses on the pathogenetic mechanisms of diseases, human, non-pharmaceutical (vaccines, biological drugs, gene and cell therapy) and pharmaceutical therapies.
  • The Pharmaceutical curriculum focuses on biotechnologies applied to the design, research and development, and analysis of innovative biotechnological drugs.

The formal approval of this program by the Italian Ministry of Education is expected by June 2022.